An electrochemiluminescence assay for quantification of Denileukin Diftitox and its anti-drug antibodies in rat serum
{{output}}
Denileukin Diftitox (DD), comprising fragments of diphtheria toxin (DT) and interleukin-2 (IL2), was developed for the treatment of lymphoma and has been approved for marketing in Japan. Toxicological evaluation including pharmacokinetics and immunogenicity in... ...
